Related Articles
Implications of driver genes associated with a high tumor mutation burden identified using next‑generation sequencing on immunotherapy in hepatocellular carcinoma
Targeted sequencing of cancer‑associated genes in hepatocellular carcinoma using next‑generation sequencing
Somatic mutation profiling of liver and biliary cancer by targeted next generation sequencing
TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma Corrigendum in /10.3892/or.2022.8411
Molecular alterations in the carcinogenesis and progression of hepatocellular carcinoma: Tumor factors and background liver factors (Review)